dexxon holdings inc private company information  bloomberg july    am et company overview of dexxon holdings inc snapshot people company overview dexxon holdings inc is based in canada   canada key executives for dexxon holdings inc dexxon holdings inc does not have any key executives recorded similar private companies by industry company name region  seabright holdings ltd americas osram lighting ltd americas cca commercial credit adjusters ltd americas ysw yacht sales west incorporated americas n spro inc americas recent private companies transactions typedate target mergeracquisition august   cynapsus therapeutics inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact dexxon holdings inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close dexxon holdings ltd private company information  bloomberg july    am et company overview of dexxon holdings ltd snapshot people company overview dexxon holdings ltd is based in hadera israel south ind zoneor akivapo box hadera  israel phone     key executives for dexxon holdings ltd dexxon holdings ltd does not have any key executives recorded similar private companies by industry company name region by medimor ltd middle eastafrica pc ltd middle eastafrica  global digital distribution limited ltd middle eastafrica  international economic consulting ltd middle eastafrica biscoil ltd middle eastafrica recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact dexxon holdings ltd please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close home  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules bringing creativity to world markets dexcel pharma® is synonymous with innovation we excel at identifying opportunities and patient needs and then developing and commercializing real valueadd products where others see obstacles we see opportunities read more strong longlasting partnership we continue to build our growing international network of quality partners and look forward to uniting with new partners for future success   read more driven by innovation dexcel pharma® strives to meet the unmet needs of patients by applying innovative rd in all areas of the pharma value chain and exploiting unique capabilities with complex formulations and sophisticated regulatory strategies read more quality from start to finish all dexcel pharma® sites deploy stateoftheart equipment and are highly automated to ensure uncompromising quality read more global reach dexcel pharma® is a truly global enterprise with over  of sales generated abroad we are committed to longterm growth entering new markets and constantly enhancing our product line read more rd dexcel pharma is focused on the development of novel and proprietary formulations of existing  molecules and high complexity generic formulations read more capabilities we believe that strong manufacturing capabilities are part of our core business all our sites use state of the art equipment and are highly automated in order to ensure the highest level of quality read more pipeline product therapeutic area development stage preclinical  formulation clinical development registration expected launch undisclosed otc  undisclosed otc  periochip®new indication dental  undisclosed ophthalmology  full pipeline success all products omeprazole delayed released tablet dexcel pharma’s proprietary formulation of omeprazole mg delayed release tablet was launched in march  as the first otc store brand equivalent to prilosec otc® this high quality value saving alternative has been the market leader since launch through an exclusive partnership with perrigo dexcel’s omeprazole otc is sold in nearly every pharmacy chain across the us the product continues to gain market share and produce yearoveryear growth despite increased competition from new molecules hitting the otc shelves in  dexcel’s widlberry mint omeprazole otc tablets were launched as an addition to the product line read more periochip®chlorhexidine gluconate periochip® is an innovative easy to apply biodegradable chip containing  mg of chlorhexidine gluconate – a non antibiotic adjunct treatment to scaling and root planing srp and is ideal for reducing pocket depth in patients with adult periodontitis periochip® is clinically effective and well tolerated in the treatment of periodontal pockets with depth of  mm and more since launch millions of chips have been administered by dental professionals across the globe and our strong commitment to working closely with doctors and clinics helps them adopt periochip® into their practices as st line treatment for longterm growth periochip is manufactured in israel and sold successfully in various countries around europe usa israel and the asia pacific region read more deximune® ciclosporin the dexcel pharma team of formulation experts developed deximune® – a softgelatin capsule formulation bioequivalent to neoral® deximune® is an immunosuppressant used following transplants and in the field of dermatology deximune® is licensed for all ciclosporin indications and is sold in various european countries israel  singapore read more a career at dexcel at dexcel the success of our company and its employees are one excellence and professionalism prevail in everything we do if you believe in creating a work environment where customers and employees are at all times equally valued and highly respected and where fairness teamwork and success abound then we invite you to submit an application to work with us read more strategic investments roivant sciences roivant sciences is a unique biopharmaceutical firm dedicated to realizing the full value of promising drug candidates by advancing them from latestage clinical development to commercialization read more cynapsus therapeutics cynapsus is a clinicalstage specialty pharmaceutical company developing a convenient and easy to use sublingual thin film strip to manage off episodes associated with parkinson’s disease read more dexcel worldwide read more united kingdom dexcel pharma ltd  sopwith way drayton fields daventry uk northamptonshire nn pb t     e officedexcelcom israel corporate headquarters  dexcel st or akiva  israel t      f      e infodexcelcom w wwwdexcelcom germany dexcel pharma gmbh carlzeissstraße  d alzenau t     e servicedexcelcom w wwwdexcelpharmade   ethics  business conduct  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules profile dexcel in numbers history worldwide executive team strategic investments events business ethics ethics  business conduct dexcel pharma readily affirms its commitment to maintaining the highest standards of ethical conduct and strict compliance with the guidelines rules and regulations that govern our business practices our core values – integrity ethical behavior commitment to quality and professionalism – demonstrate our pledge to excel in every aspect of our business   as part of this commitment dexcel pharma has established certain principles designed to guide employees and business partners in their businessrelated actions to avoid potential misconduct including a complete ban on exerting any kind of bribery or improper influence in any type of business transaction   additionally dexcel pharma recognizes that human trafficking is a serious crime and a grave violation of human rights and has adopted policies to combat human trafficking in its supply chain including requiring the inclusion of an appropriate antihuman trafficking clause in relevant supply chain agreements   dexcel pharma expects all of its employees and business partners to conduct themselves in compliance with both their legal and ethical responsibilities in all daily business operations dexcel pharma is unreservedly committed to the foregoing and will forgo any business transactions that would violate it   dexcel pharma’s risk assessment committee will periodically assess the group’s effectiveness in ensuring that bribery and human trafficking are not taking place in its business or supply chains   we look forward to working with our business partners in a manner which will allow us to demonstrate our commitment to our principles of ethical behavior and our record as an excellent corporate citizen recruitment  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules careers recruitment jobs recruitment how to apply to apply for a position at dexcel please send your resume using the link on the open positions page resumes are reviewed by the recruitment coordinator if it is determined that you are a potential candidate for the position you will hear from the recruitment coordinator who will conduct a preliminary telephone interview this interview will cover your experience and the details of the position candidates who pass this stage are invited for a frontal interview dexcel worldwide  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules profile dexcel in numbers history worldwide executive team strategic investments events business ethics dexcel worldwide we are committed to longterm growth entering new markets and constantly enhancing our product line operating throughout the world makes us more responsive helps us to identify opportunities and understand the challenges in the markets where our products are sold today approximately  of our revenues are generated outside of israel making dexcel a truly global enterprise united kingdom dexcel pharma ltd  sopwith way drayton fields daventry uk northamptonshire nn pb t     e officedexcelcom israel corporate headquarters  dexcel st or akiva  israel t      f      e infodexcelcom w wwwdexcelcom germany dexcel pharma gmbh carlzeissstraße  d alzenau t     e servicedexcelcom w wwwdexcelpharmade israel corporate headquarters  dexcel st or akiva  israel t      f      e infodexcelcom  w wwwdexcelcom uk dexcel pharma ltd  sopwith way drayton fields daventry northamptonshire nn pb uk t     e officedexcelcom germany dexcel pharma gmbh carlzeissstraße  d alzenau t     e servicedexcelcom w wwwdexcelpharmade dexcel network dexcel offers a range of value added branded and generic products through a global network of subsidiaries distributors and partners in over  markets we utilize dual commercial models for branded and generic  products operate targeted sales forces to physicians and deploy a range of sales strategies suited to specific products and territories dexcel’s products are promoted by specialty salesforces supporting flagship products such as periochip® our state of the art manufacturing capabilities allow us to be among the top suppliers of generics in western europe including germany and the uk we are eager to expand into new markets for information on joining the dexcel global network please contact us microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft dexxon holdings ltd  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors dexxon holdings ltd check out list of companies and businesses related to dexxon holdings ltd find out dexxon holdings ltd address and contact details view other people related to dexxon holdings ltd  coworkers colleagues companions etc address  dexcel street or akiva  israel companies related to dexxon holdings ltd cikcompany namepositioncompany addressarbutus biopharma corp glenlyon parkway burnaby vj jaxovant sciences ltd bedford row london wcr jsmyovant sciences ltd bedford row london wcr js dexxon holdings ltd on the web persons related to dexxon holdings ltd  arbutus biopharma corpnamepositioncitymichael j abramsmanaging director burnabypaul a brennanburnabydaniel d burgessdirector san diegoherbert j conraddirector middletonbruce cousinsevp  chief financial officer burnabyjewell donaldburnabyarthur bruskin drburnabyian maclachlan drburnabymark murray drburnabymichael abrams drburnabydiane gardinerburnabyfrashier garyburnabyole andreas halvorsengreenwichrichard c henriques jrdirector whitehouse stationrichard c henriques jrburnabypatrick t higginsburnabyelizabeth howardexec vp  general counsel burnabymortimer ianburnabyhudson jamesburnabydonald gordon jewellburnabyfrank karbedirector south san franciscofrank karbeburnabydaniel l kisnersan diegodaniel l kisnerburnabymark kowalskisr vp  chief medical officer burnabyandrew lohamiltonpeter lutwychechief technology officer burnabyclarence patrick machadosan franciscokeith s manchesterdirector forrest michaelburnabymark j murraypresident  ceo burnabydan orenor akivadavid c ottgreenwichpeggy v phillipsberkeleypeggy v phillipsburnabyqvt associates gp llcnew yorkqvt fund v lpnew yorkian lennox rburnabyvivek ramaswamydirector burnabyroivant sciences ltdhamiltonrose sharon shabetgreenwichmichael j sofiachief scientific officer burnabydaniel s sundheimgreenwichwilliam t symondschief development officer burnabyvge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities illiquid investments submaster lpgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwichpersons related to dexxon holdings ltd  axovant sciences ltdnamepositioncitymichael adasczikprincipal accounting officer new yorkmark altmeyerpres asg  chief comm ofc new yorkchristine mikail cvijicchief admin officer and gc seattlekathryn e falbergdirector rockvillelawrence md phd friedhoffchief development officer new yorkole andreas halvorsengreenwichdavid hungprincipal executive officer san franciscoandrew lohamiltonclarence patrick machadodirector san franciscomarion mccourtprincipal operating officer san franciscoberndt modigdirector new yorkstephen frederick mohrgeneral counsel new yorklawrence s olanoffdirector new yorkdan orenor akivailan orennew yorkdavid c ottgreenwichatul pandedirector new yorkgary p pisanodirector new yorkqvt associates gp llcnew yorkqvt fund v lpnew yorkvivek ramaswamyprincipal executive officer burnabyalan s roemernew yorkroivant sciences ltdhamiltonmarianne l romeoheadglobal trans  risk mgmt hamiltonrose sharon shabetgreenwichdaniel s sundheimgreenwichw anthony vernondirector san franciscovge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities illiquid investments submaster lpgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwichgregory m weinhoffprincipal financial officer stamfordpersons related to dexxon holdings ltd  myovant sciences ltdnamepositioncitymark altmeyerdirector new yorkterrie currandirector new yorkwayne s deveydtdirector indianapolisole andreas halvorsengreenwichfrank karbesouth san franciscomatthew langgeneral counsel  corp secy brisbaneandrew lohamiltonclarence patrick machadosan franciscokeith s manchesterdan orenor akivadavid c ottgreenwichqvt associates gp llcnew yorkqvt fund v lpnew yorkvivek ramaswamyburnabyroivant sciences ltdhamiltonmarianne l romeohamiltonkathleen sebeliusdirector menlo parklynn seelyprincipal executive officer san franciscorose sharon shabetgreenwichdaniel s sundheimgreenwichpharmaceuticals international ag takeda owner zurichvge iii portfolio ltdgreenwichviking global equities ii lpgreenwichviking global equities lpgreenwichviking global investors lpgreenwichviking global opportunities gp llcgreenwichviking global opportunities illiquid investments submaster lpgreenwichviking global opportunities portfolio gp llcgreenwichviking global performance llcgreenwichviking long fund gp llcgreenwichviking long fund master ltdgreenwich capabilities  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules capabilities at dexcel we believe that strong manufacturing capabilities are part of our core business all our sites use state of the art equipment and are highly automated in order to ensure the highest level of quality   dexcel manufacturing facilities employ cuttingedge computercontrolled technologies including electronic batch recording automated warehousing end of line automation and more this facilitates optimization of production and reduces human error   our global supply chain management and responsive service ensure consistency competitive pricing timely delivery and efficient inventory control quality all our production sites are approved by the fda and ema and are operating according to cgmp standards we enjoy an excellent track record with regulatory authorities partners and customers manufacturing capabilities dexcel specializes in the manufacturing of modified release oral solid dosage products our facilities operate  hours a day and have a combined manufacturing capacity of over  billion units per year manufacturing and rd sites yokneam our bulk manufacturing site in yokneam is highly automated and was specially designed for efficient manufacturing of high volume products or akiva our campus in or akiva is designed for mid volume products including state of the art packaging and qc facilities dexcel’s headquarters are located in or akiva jerusalem our jerusalem site is designed for the production of low volume specialty products and also serves as an rd center no manufacturing in jerusalem to date events  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules profile dexcel in numbers history worldwide executive team strategic investments events business ethics events past events april    singapore idem continues to play a strategic role for exhibitors in the dental industry by facilitating development and outreach into the highly dynamic asiapacific region join us  to discover the latest innovations and trends in dentistry view website september   kiev medvin top event for ukrainian dental sector it presents existing brands and new players of country’s dental market the th international dental scientific forum will take place during the event  view website february   cologne germany ids visit us at the top event for the international dental sector ids  will present the entire range of products available and brings together all relevant target groups from the worldwide dental sector view website june    stand  capital hall europerio  visit us in london at the europerio congress the world’s leading conference in periodontology and implant dentistry and the essential triennial fixture on the meetings calendar send cv  dexcel periochip® a biodegradable periodontal chip releasing mg chlorhexidine gluconate over a period of  days view dexcels vision novel otc formulation novel formulation of a wellknown us otc brand omeprazole dr tablets proprietary delayed release tablet formulation of omeprazole otc complex injectablecodevelopment complex injectable product equivalent to a wellknown brand in the oncology field codeveloped with cspc pharma viepax® xrvenlafaxine xr tablets proprietary extended release tablet formulation bioequivalent to capsule effexor xr capsules careers recruitment jobs send cv thank you your message was sent successfully  required field fill out the details to apply for the job choose a subjectgeneral browse upload cv dexcel pharma does not have any operations in nor any opportunities for internships or employment in the united states if you have received an unsolicited offer of employment or have responded to an online job posting promising employment with dexcel pharma in the united states we suggest that you contact your local police or the fbi through its internet crime complaint center website wwwicgovdefaultaspx dexxon holdings ltd business services in or akiva  dunsguide dunsguide israels business guide eng eng עבר connect connect full name forgot your password register forgot your password register to reset password please enter your email new password has been sent log in search by business field name of business enter keyword for search region not found create your business page homepage business services business services sharon area or akiva dexxon holdings ltd dexxon holdings ltd דקסון אחזקות בעמ call order db report claim your business  add to favorites also known as hebrew name דקסון אחזקות בעמ phone number  fax number  mailing address  or akiva  opening hours languages service areas report an error fields of activity marketing and business consulting business services management and maintenance of properties medical equipment medicines pharmacies specialty business services holding companies proprietary medicines business data view more details more businesses related to business services dbs credibility mark is a seal of approval designed to reflect a level of business credibility and ease a consumers decision making process as they move towards a business transaction this stamp is based on our professional opinion and on the information we have as to the quality levels of the products or services offered call facebook twitter google linkedin email  established selected business services businesses around you established real estate  construction high tech  computing services engineering  architecture businesses interior design law firms accounting firms additional fields all you need to know about businesses in israel and worldwide before engaging in any business relationship you should gather as much information as you can regarding who you seek to get involved with that is exactly why we exist we provide an extensive database that will show you everything you need to know about other businesses and companies so that you will be able to make informed decisions before committing locate potential customers how financially stable the business youre interested in actually is is this business connection an unnecessary risk or a golden opportunity this elaborate report was designed by our specialists based on the questioning of interested parties business environment analysis and professional risk assessment view demo ownership structure ownership percentages parent companies subsidiaries executives youll find it all here through this dynamic system featuring information on ownership ties crossholdings and risk rates you can have a clearer image of the company in question from a legal business and personal perspective view demo crossreferencing business data show me your friends and ill tell you who you are is an accurate saying for the business world as well that is why we created a special report that examines business ties thus reflecting potential risks or opportunities within business relationships view demo business information and credit risk management report knowledge is power and we have quite a lot of it when it comes to demographics targeted down to the finest detail here you can find new audiences for your business to generate additional growth view demo locate potential customers ownership structure crossreferencing business data business information and credit risk management report sign up to dunsguide and enjoy full name  mandatory field i accept the sites term of use i agree to receive promotional content already registeredlog in now registration complete continue to site if you wish to purchase one of our products or services please contact us business information and credit risk management report crossreferencing business data ownership structure locate potential customers contact a representative or call  שעות פעילות sunthu  order db report full name or call  opening hours sunthu  call all you need to know about businesses in israel and worldwide thank you for contacting us continue to site contact us dexxon holdings ltd or call  call thank you for contacting us continue to site report an error business owner update your information here contact us by phone  business owner update your information here contact us by phone  call or write to us thank you for contacting us continue to site dexxon holdings ltd create your business page full name       mandatory field thank you for contacting us continue to site about dunsguide advertise on dunsguide about db about credibility mark information solutions sign me up dunsguide blog contact us dbs credibility mark is a seal of approval designed to reflect a level of business credibility and ease a consumers decision making process as they move towards a business transaction this stamp is based on our professional opinion and on the information we have as to the quality levels of the products or services offered dexxon holdings ltd top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active dexxon holdings ltd • or akiva l how do i update this listing dexxon holdings ltd is based out of or akiva whalewisdom has at least  dg filings in our database for dexxon holdings ltd summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from dexxon holdings ltd enter your email address below and choose submit your email cancel contact info dexxon holdings ltd  dexcel street or akiva l     business phone  recent sec filings sc g filed on   filed on  sc da filed on  sc d filed on  sc d filed on   filed on   filed on  sc d filed on  sc da filed on   filed on  current dg holdings stock sector shares held market value rank source source date axovant sciences ltd axon health care    d  myovant sciences myov health care    g  arbutus biophrm abus health care    d  cynapsus therapeutics inc cyna health care    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free   scrip in order to deliver a personalized responsive service and to improve the site we remember and store information about how you use it this is done using simple text files called cookies which sit on your computer by continuing to use this site and access its features you are consenting to our use of cookies to find out more about the way informa uses cookies please go to our cookie policy page scrip is part of the business intelligence division of informa plc informa plc about us investor relations talent this site is operated by a business or businesses owned by informa plc and all copyright resides with them informa plc’s registered office is  howick place london swp wg registered in england and wales number  informa toggle menu menu other publications in vivo  medtech insight  pink sheet  rose sheet  register sign in this copy is for your personal noncommercial use for highquality copies or electronic reprints for distribution to colleagues or customers please call      printed by usernamepublicrestriction already registered sign in to continue reading your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom new to scrip request a free trial today free trial register for our free email digests your username does not meet the requirements an account with that username already exists unfortunately weve not been able to process your registration please contact support register toggle menu menu home commercial companies deals strategy market access market intelligence appointments research  development clinical trials approvals therapy areas pipeline watch policy  regulation hot topics us election  pricing debate brexit regional coverage meet the team scrip awards scrip  scrip asia  ask the analyst pdf library rss feeds free trial request subscribe advertise usernamepublicrestriction already registered sign in to continue reading your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom new to scrip request a free trial today free trial register for our free email digests your username does not meet the requirements an account with that username already exists unfortunately weve not been able to process your registration please contact support register email share dexxon ltd latest from dexxon ltd bookmark  apr  medigus ltd medigus ltd combines an endoscopic stapler with a miniaturized ultrasonic sighting system in a tool designed to permit surgeons to convert open or laparoscopic surgeries to leastinvasive endoscopic surgeries medical device see all company information industry pharmaceuticals drug delivery controlled release therapeutic areas nonspecific aliases ownership headquarters worldwide middle east israel parent  subsidiaries dexxon ltd dexcel pharma ltd senior management dan oren managing dirrafi lahav dir rdmati doron dir sales  mktg contact info dexxon ltd phone      herzl street tirat hacarhel haifa  israel advertisement advertisement you must sign in to use this functionality your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom authenticationsigninheadsigninheader your login andor password information does not match our records please try again forgot your password remember me sign in thanks weve sent a link to reset your password forgot your password   enter the email address associated with your account and an email will be sent to you to reset your password please enter a valid email address unfortunately weve not been able to process this request submit need help please call uk support at      us support at     or onlineaccessinformacom usernamepublicrestriction register your username does not meet the requirements sorry  this email domain is not allowed sorry  public email accounts are not allowed please provide a work email address an account with that username already exists unfortunately weve not been able to process your registration please contact support register dexxon ltd email company all set this article has been sent to myemailaddress all fields are required for multiple recipients separate email addresses with a semicolon please make sure all fields are completed please enter a valid email address please make sure you have filled out all fields please make sure you have filled out all fields subject dexxon ltd add a personalized message to your email cancel send dcdemailpopoutnotice × this copy is for your personal noncommercial use for highquality copies or electronic reprints for distribution to colleagues or customers please call      printed by dexxon holdings ltd early warning report issued pursuant to national instrument homemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  minssp futures dow futures nasdaq futures dexxon holdings ltd early warning report issued pursuant to national instrument marketwiredapril  reblogsharetweetsharemontreal quebecmarketwired  apr    this press release is issued by dexxon holdings ltd the offeror pursuant to the early warning requirements of applicable securities legislation and national instrument   the early warning system and related takeover bid and insider reporting issues with respect to common shares common shares in the capital of cynapsus therapeutics inc the companyon march   the offeror acquired ownership of  common shares in the capital of the company in consideration for the payment by the offeror of cad pursuant to and in accordance with the terms of a subscription agreement between the offeror and the company the acquisition of the offeror of the common shares resulted in the offeror ownership of approximately  of all the issued and outstanding common shares on a nonfully diluted basis following completion of the purchase of the common shares the offeror owns or controls  common shares of the companythe common shares were acquired by the offeror through a private placement pursuant to section  accredited investor of national instrument   prospectus and registration exemptions the common shares were acquired at a price of cad per common share and are subject to a hold period which will expire four months plus one day from the date of issuethe common shares were purchased by the offeror for investment purposes the offeror may in the future take such actions in respect of its holdings in the company as it may deem appropriate in light of the circumstances then existing including the purchase of additional common shares warrants or other securities of the company through open market purchases or privately negotiated transactions or the sale of all or a portion of the offerors holdings in the open market or in privately negotiated transactions to one or more purchasers subject in each case to applicable securities lawsa copy of the early warning report filed under applicable securities legislation in connection with the purchase of the common shares is available under the companys profile on the sedar website at wwwsedarcomdexxon holdings ltdby dan orenname dan orentitle directorreblogsharetweetsharerecently viewedyour list is emptywhat to read nextboeing shares surge as it lifts outlook boosts buybacksafpengineer finds pattern makes millions in stocksmoney morningsponsoredtrump’s unwitting legacy could be universal health coverageyahoo financesean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderconsumers businesses lift us economic growth in second quarterreuterszuckerberg wifes ambitious secret finally exposedunewzmesponsoredchesapeake energy corporation chk stock is a big buy under investorplacetwitter is only famous now because of president trump nyse traderyahoo finance videogdp — what you need to know in markets on fridayyahoo financethis will be in everyones household by banyan hillsponsoredrepublicans warn trump no confirmation hearing for a sessions replacement and no recess appointment eitherbusiness insiderstarbucks ceo the amazonwhole foods deal shows where retail is goingyahoo financemattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidera pennycrypto miracle making some americans richagora financialsponsoredwhy snap inc snap stock needs more than millennial power to thriveinvestorplaceamazon could be the first trillion dollar company nyse traderyahoo finance videosenate skinny repeal of obamacare falls apart on senate floor after mccain defectsdonovan  republicans and  democrats let the american people down sorry trump but all i see is one incompetent idiot in the white house who have let the american people downjoin the conversation  k dexxon holdings ltd  arbutus biopharma corporation insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsdexxon holdings ltdarbutus biopharma corporation abusten percent ownerranked  out of  insiders on tipranksdexxon holdings ltds performanceprofitable transactions out of  profitable transactionsaverage returnaverage return per transactioneach transaction is measured over a  year months month period and compared to no benchmarksp sectorhow are insiders ranked insider holdings  axovant sciences axon  arbutus biopharma corporation abusbsee the top stocks by insiders  insider rolesaxovant sciences axon ten percent ownerarbutus biopharma corporation abus ten percent ownersee the top  corporate insiders  most profitable insider tradestock axovant sciences axontransaction type informative buydates jul    jul  gain see the latest stocks traded by insiders  dexxon holdings ltds trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateabusarbutus biopharma corporationten percent ownerinformative buyundisclosedjul  axonaxovant sciencesten percent ownerinformative buyundisclosedjul  see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by